WVE
Wave Life Sciences Ltd.
NASDAQ · Healthcare · Biotechnology · SG
$3.65
+2.00%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 18.60x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.79x
- Price / sales
- 10.15x
- Price / cash flow
- -3.60x
Enterprise value
- Enterprise value
- $332.7M
- EV / sales
- 4.69x
- EV / EBITDA
- -1.62x
- EV / EBIT
- -1.46x
- Market cap
- $720.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026